Hyderabad Telangana, India

Mukkera Venkati

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hetero Research Foundation. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mukkera Venkati. Retrieved from https://idiyas.com/inventor/mukkera-venkati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mukkera Venkati: Innovator in HIV Research

Introduction

Mukkera Venkati is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds aimed at combating viral diseases.

Latest Patents

Mukkera Venkati holds a patent for "Betulinic acid proline derivatives as HIV inhibitors." This invention relates to novel betulinic acid derivatives and related compounds, as well as pharmaceutical compositions that are useful for the therapeutic treatment of viral diseases, specifically those mediated by HIV. He has 1 patent to his name.

Career Highlights

Venkati is associated with the Hetero Research Foundation, where he engages in innovative research aimed at developing effective treatments for viral infections. His work is crucial in the ongoing battle against HIV and other viral diseases.

Collaborations

Some of his notable coworkers include Bandi Parthasaradhi Reddy and Kura Rathnakar Reddy. Their collaborative efforts contribute to the advancement of research in the field of pharmaceuticals.

Conclusion

Mukkera Venkati's work exemplifies the importance of innovation in the fight against viral diseases. His contributions through patents and research are vital for the development of new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…